March 17, 2021
According to report titled ‘Global Continuous Glucose Monitor (CGM) Market- Analysis By Component, By End User, By Demographics, By Region, By Country (2020 Edition): Market Insights, COVID-19 Implications, Competition and Forecast (2020-2025)’, available with Market Study Report, global continuous glucose monitor market was worth USD 4245.67 million in 2019 and is projected to grow at a rate of 17.24% during 2020-2025.
As per the findings of the report, global continuous glucose monitor (CGM) market is mainly driven by increasing cases of diabetes among children and elderly population base. Moreover, with the necessity of monitoring sugar levels daily among the diabetic population, glucose monitoring devices will witness an increased demand throughout the forecast period. Besides, easily usability of CGM is further encouraging the product demand.
Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/3056137/
Based on component, global continuous glucose monitor (CGM) market is categorized into sensors, transmitter & receivers, and integrated insulin pumps. Among these, sensors is witnessing an increased demand across the globe with over 48.61% of the market share in 2019, trailed by transmitter & receiver at 28.34%.
Under the end-user spectrum, global continuous glucose monitor (CGM) industry is fragmented into homecare and hospital, among which, the former anticipated to capture majority of the industry share in the forthcoming years. This can be ascribed to rising cases of hypo and hyperglycemia, along with ease of conducting tests via CGM.
Elaborating on the demographics segment, the industry is split into adults and pediatric. Of these, adults segment is slated to secure the largest market share during the forecast duration, fueled by greater prevalence of diabetes among young and older population.
Considering the geographical scope, the key contributors to global continuous glucose monitor (CGM) market remuneration are Europe (United Kingdom, Germany, France, and Italy), North America (United States and Canada), and Asia Pacific (India, China, South Korea, Japan).
Speaking of the competitive landscape, Hoffmann-La Roche AG, AgaMatrix, Inc., Integrity Applications, Senseonics Holdings, Ascensia Diabetes Care Holdings AG, Glysens, Inc., Insulet Corp., Abbott Laboratories, DexCom, Inc., and Medtronic plc are the top cotnders in global continuous glucose monitor (CGM) market sphere.